Prenatal diagnosis is based on either non-invasive testing methods, such as NIPT (tests fetal chromosomes circulating in the maternal blood stream), or invasive methods, such as amniocentesis or chorionic villus sampling (CVS). We are currently in the process of building our pre-implantation diagnosis (PGD) clinic to enable providing genetic diagnosis of in-vitro fertilization (IVF) embryos prior to implantation. This is a core activity directed towards preventing the recurrence of genetic conditions and hereditary disorders.
Our oncogenetic clinic serves as a referral center and provides counseling and DNA-based diagnostics for patients with various types of cancer, e.g. breast, ovarian, colon, uterine, pancreatic, and thyroid.
The Genetic Institute takes an active role in teaching and training physicians and health-care providers at the Rambam Health Care Campus and at the Technion’s Ruth and Bruce Rappaport Faculty of Medicine. We are engaged in a variety of exciting research projects aimed at deciphering the molecular basis of a range of genetic conditions, both rare and common. Establishing a molecular diagnosis holds a high value for future family planning and may contribute to science by uncovering genotype-phenotype associations and provide a better understanding of disease pathways.